Free tool
Stocks listed on ASX
We cover 155 companies listed on ASX. The median market value in the group is $35.49M. Across the group, the median move over the past trading day is 0.00%. 34% of the 150 with a 200-day average trade above it. Price change over the past year runs from −72.7% to +70.3% across the middle 80 percent of the group, with a median of −17.8%.
Other lists in this group
Table
155 of 1,792 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| CSL.AX | CSL Limited | $59.98B | Large cap | −17.14% |
| RMD.AX | ResMed Inc. | $34.05B | Large cap | −24.73% |
| SIG.AX | Sigma Healthcare Limited | $23.62B | Large cap | −5.33% |
| FPH.AX | Fisher & Paykel Healthcare Corporation Limited | $15.80B | Large cap | +13.60% |
| PME.AX | Pro Medicus Limited | $14.09B | Large cap | −38.33% |
| RHCPA.AX | Ramsay Health Care Limited | $10.16B | Large cap | +0.44% |
| RHC.AX | Ramsay Health Care Limited | $7.33B | Mid cap | +18.74% |
| SHL.AX | Sonic Healthcare Limited | $7.20B | Mid cap | −11.60% |
| COH.AX | Cochlear Limited | $6.38B | Mid cap | −53.16% |
| ANN.AX | Ansell Limited | $4.17B | Mid cap | +22.31% |
| TLX.AX | Telix Pharmaceuticals Limited | $3.91B | Mid cap | −12.72% |
| EBO.AX | EBOS Group Limited | $2.72B | Mid cap | −35.38% |
| MSB.AX | Mesoblast Limited | $2.25B | Mid cap | −3.82% |
| NEU.AX | Neuren Pharmaceuticals Limited | $2.08B | Mid cap | +18.47% |
| 4DX.AX | 4DMedical Limited | $1.65B | Small cap | +652.94% |
| PYC.AX | PYC Therapeutics Limited | $1.48B | Small cap | +63.71% |
| REG.AX | Regis Healthcare Limited | $1.32B | Small cap | −19.77% |
| RYM.AX | RYM FPO NZX [RYM] | $1.26B | Small cap | −28.42% |
| SNZ.AX | Summerset Group Holdings Limited | $1.12B | Small cap | −32.53% |
| AVR.AX | Anteris Technologies Global Corp. | $863.83M | Small cap | +102.52% |
| EIQ.AX | Echo IQ Limited | $795.46M | Small cap | +653.66% |
| CU6.AX | Clarity Pharmaceuticals Ltd | $669.65M | Small cap | −27.91% |
| IDX.AX | Integral Diagnostics Limited | $638.89M | Small cap | −17.78% |
| NAN.AX | Nanosonics Limited | $621.12M | Small cap | −34.23% |
| AYA.AX | Artrya Limited | $539.15M | Small cap | +124.02% |
| IMR.AX | Imricor Medical Systems, Inc. | $493.27M | Small cap | +41.54% |
| PNV.AX | PolyNovo Limited | $485.11M | Small cap | −27.14% |
| ACL.AX | Australian Clinical Labs Limited | $386.24M | Small cap | +12.06% |
| CUV.AX | Clinuvel Pharmaceuticals Limited | $381.21M | Small cap | −21.84% |
| CGS.AX | Cogstate Limited | $376.22M | Small cap | +80.70% |
| OCA.AX | Oceania Healthcare Limited | $352.00M | Small cap | +11.57% |
| AVH.AX | AVITA Medical, Inc. | $324.65M | Small cap | +108.57% |
| RAC.AX | Racura Oncology Ltd | $303.46M | Small cap | +72.00% |
| AFP.AX | AFT Pharmaceuticals Limited | $278.02M | Small cap | +54.17% |
| TTX.AX | Tetratherix Limited | $253.20M | Small cap | +62.44% |
| SPL.AX | Starpharma Holdings Limited | $252.95M | Small cap | +465.38% |
| HLS.AX | Healius Limited | $224.62M | Small cap | −55.00% |
| MVF.AX | Monash IVF Group Limited | $198.22M | Small cap | +5.55% |
| MYX.AX | Mayne Pharma Group Limited | $185.13M | Small cap | −38.27% |
| PEB.AX | Pacific Edge Limited | $182.42M | Small cap | +64.00% |
| EBR.AX | EBR Systems, Inc. | $159.24M | Small cap | −78.47% |
| PGC.AX | Paragon Care Limited | $154.19M | Small cap | −65.79% |
| OCC.AX | Orthocell Limited | $152.21M | Small cap | −35.00% |
| ARX.AX | Aroa Biosurgery Limited | $142.81M | Small cap | −10.24% |
| NYR.AX | Nyrada Inc. | $138.38M | Small cap | +231.91% |
| DXB.AX | Dimerix Limited | $131.21M | Small cap | −35.79% |
| EMV.AX | EMVision Medical Devices Ltd | $119.89M | Small cap | −5.26% |
| SDI.AX | SDI Ltd | $118.98M | Small cap | +59.51% |
| ACW.AX | Actinogen Medical Limited | $117.55M | Small cap | +51.72% |
| ONE.AX | Oneview Healthcare PLC | $100.82M | Small cap | −34.04% |
| ILA.AX | Island Pharmaceuticals Limited | $99.59M | Micro cap | +104.35% |
| PAR.AX | Paradigm Biopharmaceuticals Limited | $96.60M | Micro cap | −22.41% |
| BB1.AX | BLINKLAB FPO [BB1] | $93.89M | Micro cap | +67.65% |
| ALC.AX | Alcidion Group Limited | $92.38M | Micro cap | −7.62% |
| ATH.AX | Alterity Therapeutics Limited | $81.04M | Micro cap | −20.00% |
| RCE.AX | Recce Pharmaceuticals Ltd | $81.01M | Micro cap | −12.79% |
| LDX.AX | Lumos Diagnostics Holdings Limited | $67.70M | Micro cap | −19.23% |
| LTP.AX | LTR PHARMA FPO [LTP] | $65.08M | Micro cap | −2.00% |
| AHC.AX | Austco Healthcare Limited | $61.76M | Micro cap | −36.11% |
| IMM.AX | Immutep Limited | $57.02M | Micro cap | −77.96% |
| ATX.AX | Amplia Therapeutics Limited | $56.97M | Micro cap | −13.53% |
| AVE.AX | Avecho Biotechnology Limited | $55.33M | Micro cap | +200.00% |
| SOM.AX | SomnoMed Limited | $53.50M | Micro cap | −56.13% |
| ALA.AX | Arovella Therapeutics Limited | $52.84M | Micro cap | −26.19% |
| PTX.AX | Prescient Therapeutics Limited | $50.48M | Micro cap | +58.14% |
| PHX.AX | PharmX Technologies Limited | $50.12M | Micro cap | −4.55% |
| M7T.AX | Mach7 Technologies Limited | $47.99M | Micro cap | −9.52% |
| CYC.AX | Cyclopharm Limited | $46.85M | Micro cap | −47.50% |
| ENP.AX | Entropy Neurodynamics Limited | $45.59M | Micro cap | +5.41% |
| CTE.AX | Cryosite Limited | $43.72M | Micro cap | +56.25% |
| MVP.AX | Medical Developments International Limited | $41.73M | Micro cap | −13.01% |
| LGP.AX | Little Green Pharma Ltd | $41.50M | Micro cap | −44.00% |
| SHG.AX | Singular Health Group Ltd | $40.89M | Micro cap | −47.76% |
| BOT.AX | Botanix Pharmaceuticals Limited | $39.22M | Micro cap | −87.10% |
| PKY.AX | Pathkey.AI Ltd | $38.71M | Micro cap | +81.82% |
| CMP.AX | Compumedics Limited | $37.93M | Micro cap | −7.02% |
| SNT.AX | Syntara Limited | $36.57M | Micro cap | −1.89% |
| NXN.AX | Nexsen Ltd | $34.40M | Micro cap | −17.86% |
| COV.AX | Cleo Diagnostics Ltd | $33.34M | Micro cap | −5.56% |
| NUZ.AX | Neurizon Therapeutics Limited | $32.19M | Micro cap | −63.75% |
| DOC.AX | Doctor Care Anywhere Group PLC | $31.56M | Micro cap | −7.69% |
| HMD.AX | HeraMED Limited | $31.55M | Micro cap | +15.15% |
| EYE.AX | Nova Eye Medical Limited | $29.60M | Micro cap | 0.00% |
| EMD.AX | Emyria Limited | $27.16M | Micro cap | −10.00% |
| MAP.AX | Microba Life Sciences Limited | $27.10M | Micro cap | −42.11% |
| OSL.AX | OncoSil Medical Limited | $25.79M | Micro cap | +4.02% |
| IMU.AX | Imugene Limited | $25.70M | Micro cap | −73.33% |
| ENL.AX | Enlitic, Inc. | $25.36M | Micro cap | −88.64% |
| RHY.AX | Rhythm Biosciences Limited | $24.60M | Micro cap | −3.00% |
| CSX.AX | CleanSpace Holdings Limited | $23.51M | Micro cap | −52.66% |
| VHL.AX | Vitasora Health Limited | $23.48M | Micro cap | −51.72% |
| RHT.AX | Resonance Health Limited | $23.25M | Micro cap | +65.85% |
| BMT.AX | Beamtree Holdings Limited | $23.07M | Micro cap | −53.70% |
| NOX.AX | Noxopharm Limited | $20.25M | Micro cap | −20.00% |
| TRJ.AX | Trajan Group Holdings Limited | $19.70M | Micro cap | −79.57% |
| PIQ.AX | Proteomics International Laboratories Ltd | $19.54M | Micro cap | −48.44% |
| CBL.AX | Control Bionics Limited | $19.15M | Micro cap | +60.86% |
| AGN.AX | Argenica Therapeutics Limited | $18.41M | Micro cap | −70.15% |
| NSB.AX | NeuroScientific Biopharmaceuticals Limited | $18.15M | Micro cap | −59.38% |
| BDX.AX | BCAL Diagnostics Limited | $17.70M | Micro cap | −17.46% |
| IIQ.AX | INOVIQ Ltd | $17.65M | Micro cap | −56.25% |
| EZZ.AX | EZZ Life Science Holdings Limited | $17.52M | Micro cap | −78.77% |
| RAD.AX | Radiopharm Theranostics Limited | $16.95M | Micro cap | −62.96% |
| 1AI.AX | Algorae Pharmaceuticals Limited | $15.98M | Micro cap | +22.22% |
| BTC.AX | BTC Health Limited | $15.37M | Micro cap | −3.23% |
| PKP.AX | PEAK FPO [PKP] | $15.30M | Micro cap | −30.43% |
| MX1.AX | Micro-X Limited | $14.55M | Micro cap | −65.82% |
| PCK.AX | PainChek Limited | $13.92M | Micro cap | −76.15% |
| VIT.AX | Vitura Health Limited | $13.76M | Micro cap | −54.55% |
| GSS.AX | Genetic Signatures Limited | $13.51M | Micro cap | −72.33% |
| MEM.AX | Memphasys Limited | $13.27M | Micro cap | +50.00% |
| NTI.AX | Neurotech International Limited | $13.27M | Micro cap | +16.67% |
| TRI.AX | TrivarX Limited | $13.23M | Micro cap | +77.78% |
| IPD.AX | ImpediMed Limited | $13.12M | Micro cap | −88.37% |
| IDT.AX | IDT Australia Limited | $12.85M | Micro cap | −37.31% |
| ICR.AX | Intelicare Holdings Limited | $12.80M | Micro cap | +81.25% |
| IME.AX | ImExHS Limited | $12.07M | Micro cap | +37.78% |
| AT1.AX | Atomo Diagnostics Limited | $10.99M | Micro cap | −15.00% |
| CQT.AX | CONNEQT Health Limited | $9.92M | Micro cap | −44.44% |
| RNV.AX | RENERVE FPO [RNV] | $9.51M | Micro cap | −28.57% |
| CMB.AX | Cambium Bio Limited | $8.86M | Micro cap | 0.00% |
| IMC.AX | Immuron Limited | $8.33M | Micro cap | −46.38% |
| IXC.AX | Invex Therapeutics Ltd | $7.00M | Micro cap | +34.02% |
| 1AD.AX | AdAlta Limited | $6.90M | Micro cap | −12.50% |
| ECS.AX | ECS Botanics Holdings Ltd | $6.88M | Micro cap | −14.29% |
| VBS.AX | Vectus Biosystems Limited | $6.65M | Micro cap | +87.50% |
| CVB.AX | CurveBeam AI Limited | $6.58M | Micro cap | −86.67% |
| AHE.AX | Adheris Health Limited | $6.40M | Micro cap | −73.58% |
| EPN.AX | Epsilon Healthcare Limited | $6.13M | Micro cap | −8.33% |
| FRE.AX | Firebrick Pharma Limited | $5.97M | Micro cap | −61.33% |
| BGT.AX | Bio-Gene Technology Limited | $5.96M | Micro cap | −17.39% |
| CTQ.AX | Careteq Limited | $5.78M | Micro cap | +20.00% |
| IBX.AX | Imagion Biosystems Limited | $5.74M | Micro cap | −37.50% |
| PER.AX | PERCHERON FPO [PER] | $5.45M | Micro cap | −54.55% |
| ACR.AX | Acrux Limited | $4.23M | Micro cap | −28.57% |
| HIQ.AX | HITIQ Limited | $4.03M | Micro cap | −66.67% |
| BIT.AX | Biotron Limited | $3.99M | Micro cap | −33.33% |
| ADR.AX | Adherium Limited | $3.93M | Micro cap | +1900.00% |
| TRP.AX | Tissue Repair Ltd | $3.81M | Micro cap | −72.92% |
| CAN.AX | Cann Group Limited | $3.57M | Micro cap | −75.00% |
| VFX.AX | VISIONFLEX FPO [VFX] | $3.41M | Micro cap | −56.00% |
| RGT.AX | Argent BioPharma Limited | $3.18M | Micro cap | −73.10% |
| TD1.AX | TALi Digital Limited | $3.01M | Micro cap | −10.00% |
| IVX.AX | Invion Limited | $2.90M | Micro cap | −70.00% |
| GLH.AX | Global Health Limited | $2.57M | Micro cap | −44.55% |
| EXL.AX | Elixinol Wellness Limited | $2.08M | Micro cap | −58.82% |
| ANR.AX | Anatara Lifesciences Ltd | $2.04M | Micro cap | +12.50% |
| NX1.AX | Nexalis Therapeutics Limited | $1.99M | Micro cap | −50.00% |
| OSX.AX | Osteopore Limited | $1.99M | Micro cap | −63.64% |
| CYP.AX | Cynata Therapeutics Limited | $1.92M | Micro cap | −94.88% |
| OAK.AX | Oakridge International Limited | $1.72M | Micro cap | −17.58% |
| BP8.AX | BPH Global Ltd | $1.69M | Micro cap | −25.00% |
| CHM.AX | Chimeric Therapeutics Limited | $659.83K | Micro cap | −95.67% |
| EPI.AX | EPIMINDER FPO [EPI] | $62.06K | Micro cap | −70.23% |
| SLD.AX | Saluda Medical, Inc. | — | — | −50.39% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.